154 related articles for article (PubMed ID: 28883084)
1. Advances in risk-oriented surgery for multiple endocrine neoplasia type 2.
Machens A; Dralle H
Endocr Relat Cancer; 2018 Feb; 25(2):T41-T52. PubMed ID: 28883084
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results.
Machens A; Dralle H
Curr Opin Oncol; 2024 Jan; 36(1):1-12. PubMed ID: 37975407
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
[TBL] [Abstract][Full Text] [Related]
4. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
Qi XP; Chen XL; Ma JM; Du ZF; Fei J; Yang CP; Cheng J; Song QZ; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Liu WT; Zhao Y; Chen CY; Jiang HL; Ke HP; Zhang XN
Thyroid; 2012 Dec; 22(12):1257-65. PubMed ID: 23210566
[TBL] [Abstract][Full Text] [Related]
5. Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2013 Feb; 98(2):E336-45. PubMed ID: 23284010
[TBL] [Abstract][Full Text] [Related]
6. [Multiple endocrine neoplasia type 2].
Niccoli-Sire P; Conte-Devolx B
Ann Endocrinol (Paris); 2007 Oct; 68(5):317-24. PubMed ID: 17626779
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
Castinetti F; Qi XP; Walz MK; Maia AL; Sansó G; Peczkowska M; Hasse-Lazar K; Links TP; Dvorakova S; Toledo RA; Mian C; Bugalho MJ; Wohllk N; Kollyukh O; Canu L; Loli P; Bergmann SR; Biarnes Costa J; Makay O; Patocs A; Pfeifer M; Shah NS; Cuny T; Brauckhoff M; Bausch B; von Dobschuetz E; Letizia C; Barczynski M; Alevizaki MK; Czetwertynska M; Ugurlu MU; Valk G; Plukker JT; Sartorato P; Siqueira DR; Barontini M; Szperl M; Jarzab B; Verbeek HH; Zelinka T; Vlcek P; Toledo SP; Coutinho FL; Mannelli M; Recasens M; Demarquet L; Petramala L; Yaremchuk S; Zabolotnyi D; Schiavi F; Opocher G; Racz K; Januszewicz A; Weryha G; Henry JF; Brue T; Conte-Devolx B; Eng C; Neumann HP
Lancet Oncol; 2014 May; 15(6):648-55. PubMed ID: 24745698
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic adrenalectomy as an effective approach to massive bilateral pheochromocytomas.
Martins D; Rodrigues D; Melo M; Carrilho F
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28883010
[TBL] [Abstract][Full Text] [Related]
9. Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy.
Scholten A; Valk GD; Ulfman D; Borel Rinkes IH; Vriens MR
Ann Surg; 2011 Dec; 254(6):1022-7. PubMed ID: 22107743
[TBL] [Abstract][Full Text] [Related]
10. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of MEN-1 and -2: state of the art.
Akerström G; Stålberg P
Surg Clin North Am; 2009 Oct; 89(5):1047-68. PubMed ID: 19836484
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia, the old and the new: a mini review.
Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.
Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E
World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955
[TBL] [Abstract][Full Text] [Related]
14. MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives.
Amodru V; Taieb D; Guerin C; Romanet P; Paladino N; Brue T; Cuny T; Barlier A; Sebag F; Castinetti F
Endocrine; 2020 Sep; 69(3):496-503. PubMed ID: 32388798
[TBL] [Abstract][Full Text] [Related]
15. 100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A.
Machens A; Elwerr M; Lorenz K; Weber F; Dralle H
Endocrine; 2020 May; 68(2):368-376. PubMed ID: 32100189
[TBL] [Abstract][Full Text] [Related]
16. Surgical approaches in hereditary endocrine tumors.
Iacobone M; Citton M; Viel G; Schiavone D; Torresan F
Updates Surg; 2017 Jun; 69(2):181-191. PubMed ID: 28455835
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of multiple endocrine neoplasia].
Conte-Devolx B; Niccoli P;
Bull Acad Natl Med; 2010 Jan; 194(1):69-78; discussion 78-9. PubMed ID: 20669560
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Breza J; Breza J
Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
[TBL] [Abstract][Full Text] [Related]
19. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.
Asari R; Scheuba C; Kaczirek K; Niederle B
Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962
[TBL] [Abstract][Full Text] [Related]
20. [The clinical characteristics and therapy of multiple endocrine neoplasia type 2].
Xie Y; Li HZ; Rong S; Zhu Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1096-9. PubMed ID: 15498294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
